Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
-
-
-
-
-
-
-
Zymeworks appoints Brian Cherry to board, promotes executives
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $40 at Leerink Partners
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $35 at Citi
-
-
-
-
-
-
-
Zymeworks adds two directors to board of directors
-
-
-
-
-
-
-
Zymeworks (ZYME) Announces NMPA Approval of Zanidatamab in China
-
-
-
-
-
-
-
Zymeworks (ZYME) Achieves $14M Milestone from GSK Collaboration
-
398,561 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

